Population Council Advances Non-Antiretroviral Multipurpose Prevention Technology
Population Council Advances Non-Antiretroviral Multipurpose Prevention Technology
- First in-human clinical trial of griffithsin, a naturally occurring anti-HIV protein, which limits risk of cross-resistance to antiretroviral (ARV) products.
- First in-human clinical trial of griffithsin, a naturally occurring anti-HIV protein, which limits risk of cross-resistance to antiretroviral (ARV) products.